Keyword: Teva Pharmaceuticals


Teva Intends to Divest API Business

02.02.2024 -

Israeli generics manufacturer Teva Pharmaceuticals intends to divest its active pharmaceutical ingredient (API) business, Teva API (TAPI). A standalone business unit of...


Teva Contemplates Selling $2 Billion Active Ingredients Division

10.07.2023 -

Teva Pharmaceuticals considers selling its $2 billion active pharmaceutical ingredients (API) unit as part of its "Pivot to Growth" strategy.


Teva, Sun Pharma to Pay $2.15 Billion to Settle Pfizer Patent Suit

12.06.2013 - Pfizer said Teva Pharmaceuticals Industries and Sun Pharmaceutical Industries would pay $2.15 billion to settle a patent suit related to its acid-reflux drug. This is the first...


Judge Denies FDA Bid to Stay 'Morning-after' Pill Ruling

10.05.2013 - A federal judge in New York on Friday declined to temporarily halt a court order directing the U.S. Food and Drug Administration to make emergency contraception available over the...


Teva's 2013 Forecast Is Below Wall Street Estimates

30.11.2012 - Teva Pharmaceutical Industries, the world's biggest maker of generic drugs, forecast profit and revenue for calendar 2013 that fell short of analysts' estimates. The Israel-based...


Teva Pharmaceutical Adjusted Profit Tops Estimates

01.11.2012 - Teva Pharmaceutical Industries, the world's biggest generic drugmaker, posted adjusted quarterly profit that beat expectations as strong U.S. revenue offset lower European generic...


U.S. Finds No Wrongdoing in Yasmin Patent Settlement

02.10.2012 - U.S. antitrust regulators found no wrongdoing in a deal made four years ago between German drugmaker Bayer and a division of Teva Pharmaceuticals to end patent litigation over the...


Teva Cuts Profit View on Weak European Markets

24.05.2012 - Teva Pharmaceutical Industries, the world's largest maker of generic drugs, has cut its profit and revenue forecasts for 2012, blaming weaker economies and healthcare spending cuts...